• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - MAPLE GROVE ELUVIATM DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - MAPLE GROVE ELUVIATM DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING Back to Search Results
Model Number H74939238601510
Device Problems Fracture (1260); Occlusion Within Device (1423)
Patient Problem Reocclusion (1985)
Event Date 03/26/2018
Event Type  Injury  
Manufacturer Narrative
(b)(4).It is indicated that the device will not be returned for evaluation.If there is any further relevant information obtained, a supplemental medwatch will be filed.(b)(4).
 
Event Description
The patient was enrolled in the (b)(6) clinical study.It was reported that in-stent restenosis (isr) and stent fracture occurred.On (b)(6) 2016, the index procedure was performed.The target lesion was located in the right mid superficial femoral artery (sfa) extending to the distal sfa.The target lesion was 90% stenosed, 140mm long, with a proximal reference vessel diameter of 6.00mm and distal vessel diameter of 5.00mm, and was classified as a tasc ii b lesion.The target lesion was treated with pre-dilatation and a 6x150mm eluvia stent was implanted.The target lesion was then treated with post-dilatation and residual stenosis was 5%.The patient was discharged the following day with dual antiplatelet therapy.On (b)(6) 2018, the patient presented for a protocol 24 month follow-up visit.An ultrasound revealed isr in the right sfa.An x-ray was performed which revealed grade ii multiple tine fracture on the distal part of the stent.It was reported that the stent fracture was not observed in the overlap zone.On (b)(6) 2018, the patient was hospitalized for planned intervention.On (b)(6) 2018, the right mid sfa was treated with balloon angioplasty.The ostium and proximal sfa was treated with drug coated balloon angioplasty.On (b)(6) 2018, the patient was discharged from the hospital.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELUVIATM DRUG-ELUTING VASCULAR STENT SYSTEM
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC - MAPLE GROVE
one scimed place
maple grove MN 55311
Manufacturer Contact
sonali arangil
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key7538932
MDR Text Key109100085
Report Number2134265-2018-04542
Device Sequence Number1
Product Code NIU
Combination Product (y/n)N
Reporter Country CodeBE
PMA/PMN Number
SIMILAR
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 04/30/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/23/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date05/31/2016
Device Model NumberH74939238601510
Device Catalogue Number39238-60151
Device Lot Number18390231
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/30/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/28/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age60 YR
-
-